123 related articles for article (PubMed ID: 20627731)
21. MMP-2 and MMP-9 levels in peripheral blood after subarachnoid hemorrhage.
Horstmann S; Su Y; Koziol J; Meyding-Lamadé U; Nagel S; Wagner S
J Neurol Sci; 2006 Dec; 251(1-2):82-6. PubMed ID: 17087971
[TBL] [Abstract][Full Text] [Related]
22. Biochemical markers for blood-brain barrier dysfunction in acute ischemic stroke correlate with evolution and outcome.
Brouns R; Wauters A; De Surgeloose D; Mariën P; De Deyn PP
Eur Neurol; 2011; 65(1):23-31. PubMed ID: 21135557
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients.
Intiso D; Zarrelli MM; Lagioia G; Di Rienzo F; Checchia De Ambrosio C; Simone P; Tonali P; Cioffi Dagger RP
Neurol Sci; 2004 Feb; 24(6):390-6. PubMed ID: 14767684
[TBL] [Abstract][Full Text] [Related]
24. Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer.
Hrabec E; Strek M; Nowak D; Hrabec Z
Respir Med; 2001 Jan; 95(1):1-4. PubMed ID: 11207010
[TBL] [Abstract][Full Text] [Related]
25. Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease.
Chang HR; Yang SF; Li ML; Lin CC; Hsieh YS; Lian JD
Clin Chim Acta; 2006 Apr; 366(1-2):243-8. PubMed ID: 16313894
[TBL] [Abstract][Full Text] [Related]
26. Increases in circulating matrix metalloproteinase-9 levels following fibrinolysis for acute pulmonary embolism.
Mühl D; Ghosh S; Uzuelli JA; Lantos J; Tanus-Santos JE
Thromb Res; 2010 Jun; 125(6):549-53. PubMed ID: 20307903
[TBL] [Abstract][Full Text] [Related]
27. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
28. Do extracellular-matrix-regulating enzymes play a role in cervical artery dissection?
Guillon B; Peynet J; Bertrand M; Benslamia L; Bousser MG; Tzourio C
Cerebrovasc Dis; 2007; 23(4):299-303. PubMed ID: 17199088
[TBL] [Abstract][Full Text] [Related]
29. The rtPA increases MMP-9 activity in serum during ischaemic stroke.
Gołąb P; Boguszewska-Czubara A; Kiełbus M; Kurzepa J
Neurol Neurochir Pol; 2014; 48(5):309-14. PubMed ID: 25440008
[TBL] [Abstract][Full Text] [Related]
30. Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis.
Salata IM; Stojanovic N; Cajdler-Łuba A; Lewandowski KC; Lewiński A
Gynecol Endocrinol; 2008 Jun; 24(6):326-30. PubMed ID: 18584412
[TBL] [Abstract][Full Text] [Related]
31. New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke.
Rodríguez-Yáñez M; Castellanos M; Blanco M; García MM; Nombela F; Serena J; Leira R; Lizasoain I; Dávalos A; Castillo J
Neurology; 2006 Dec; 67(11):1973-8. PubMed ID: 17159103
[TBL] [Abstract][Full Text] [Related]
32. Serum tau protein level as a marker of axonal damage in acute ischemic stroke.
Bitsch A; Horn C; Kemmling Y; Seipelt M; Hellenbrand U; Stiefel M; Ciesielczyk B; Cepek L; Bahn E; Ratzka P; Prange H; Otto M
Eur Neurol; 2002; 47(1):45-51. PubMed ID: 11803192
[TBL] [Abstract][Full Text] [Related]
33. Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor.
Rauvala M; Puistola U; Turpeenniemi-Hujanen T
Gynecol Oncol; 2005 Dec; 99(3):656-63. PubMed ID: 16112717
[TBL] [Abstract][Full Text] [Related]
34. Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.
Rautelin HI; Oksanen AM; Veijola LI; Sipponen PI; Tervahartiala TI; Sorsa TA; Lauhio A
Ann Med; 2009; 41(3):208-15. PubMed ID: 18979291
[TBL] [Abstract][Full Text] [Related]
35. [Expression of matrix metalloproteinase MMP-9 in the plasma and hematoma fluid of intracerebral hemorrhage patients].
Wu CH; Huang FY; Wang KY; Huang SY; Yang RL; Li HZ; Lei HX; Lin JS; Wang JM; Yan XH
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):174-6. PubMed ID: 18361815
[TBL] [Abstract][Full Text] [Related]
36. Proteolytic activity during cortical development is distinct from that involved in hypoxic ischemic injury.
Ranasinghe HS; Williams CE; Christophidis LJ; Mitchell MD; Fraser M; Scheepens A
Neuroscience; 2009 Jan; 158(2):732-44. PubMed ID: 18809469
[TBL] [Abstract][Full Text] [Related]
37. Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke.
Manso H; Krug T; Sobral J; Albergaria I; Gaspar G; Ferro JM; Oliveira SA; Vicente AM
BMC Med Genet; 2010 Mar; 11():40. PubMed ID: 20222942
[TBL] [Abstract][Full Text] [Related]
38. Plasma MMP-2, MMP-9 and N-BNP in long-term survivors following complicated myocardial infarction: relation to cardiac magnetic resonance imaging measures of left ventricular structure and function.
Orn S; Manhenke C; Squire IB; Ng L; Anand I; Dickstein K
J Card Fail; 2007 Dec; 13(10):843-9. PubMed ID: 18068618
[TBL] [Abstract][Full Text] [Related]
39. The serum high-sensitive C reactive protein and homocysteine levels to evaluate the prognosis of acute ischemic stroke.
Yoldas T; Gonen M; Godekmerdan A; Ilhan F; Bayram E
Mediators Inflamm; 2007; 2007():15929. PubMed ID: 17597836
[TBL] [Abstract][Full Text] [Related]
40. Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke.
Demir R; Ulvi H; Özel L; Özdemir G; Güzelcik M; Aygül R
Acta Neurol Belg; 2012 Dec; 112(4):351-6. PubMed ID: 22581515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
